1. Home
  2. EVTC vs AGIO Comparison

EVTC vs AGIO Comparison

Compare EVTC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

SELL

Current Price

$29.77

Market Cap

1.9B

Sector

Technology

ML Signal

SELL

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

SELL

Current Price

$31.53

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
EVTC
AGIO
Founded
1988
2007
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
EVTC
AGIO
Price
$29.77
$31.53
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$35.20
★ $46.00
AVG Volume (30 Days)
437.0K
★ 914.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 0.67%
N/A
EPS Growth
★ 27.17
N/A
EPS
★ 0.47
N/A
Revenue
★ $453,869,000.00
$43,011,000.00
Revenue This Year
$16.93
$229.47
Revenue Next Year
$8.30
$94.99
P/E Ratio
$63.15
★ N/A
Revenue Growth
★ 11.48
N/A
52 Week Low
$21.81
$22.24
52 Week High
$34.41
$46.00

Technical Indicators

Market Signals
Indicator
EVTC
AGIO
Relative Strength Index (RSI) 60.41 40.06
Support Level $28.79 $26.71
Resistance Level $30.23 $35.77
Average True Range (ATR) 0.84 1.12
MACD 0.31 -0.12
Stochastic Oscillator 92.38 17.29

Price Performance

Historical Comparison
EVTC
AGIO

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: